Cargando…
Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells
Tropism of neural stem cells (NSCs) to hypoxic tumor areas provides an opportunity for the drug delivery. Here, we demonstrate that NSCs effectively transport antisense oligonucleotides (ASOs) targeting oncogenic and tolerogenic signal transducer and activator of transcription 3 (STAT3) protein into...
Autores principales: | Adamus, Tomasz, Hung, Chia-Yang, Yu, Chunsong, Kang, Elaine, Hammad, Mohamed, Flores, Linda, Nechaev, Sergey, Zhang, Qifang, Gonzaga, Joanna Marie, Muthaiyah, Kokilah, Swiderski, Piotr, Aboody, Karen S., Kortylewski, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752899/ https://www.ncbi.nlm.nih.gov/pubmed/35036069 http://dx.doi.org/10.1016/j.omtn.2021.12.029 |
Ejemplares similares
-
Systemic delivery of TLR9-activating/STAT3-blocking oligonucleotides induces leukemia regression
por: Zhang, Qifang, et al.
Publicado: (2014) -
The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018) -
Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia
por: Zhang, Qifang, et al.
Publicado: (2015) -
B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
por: Zhao, Xingli, et al.
Publicado: (2018) -
Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)